Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Brain tumor
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Oligodendrogliomas=== {{Main|Oligodendroglioma}} [[Oligodendroglioma]]s are incurable but slowly progressive malignant brain tumors. They can be treated with [[Segmental resection|surgical resection]], [[chemotherapy]], [[radiotherapy]] or a combination. For some suspected low-grade (grade II) tumors, only a course of watchful waiting and symptomatic therapy is opted for. These tumors show co-deletions of the p and q arms of [[chromosome 1 (human)|chromosome 1]] and [[chromosome 19 (human)|chromosome 19]] respectively (1p19q co-deletion) and have been found to be especially chemosensitive with one report claiming them to be one of the most chemosensitive tumors.<ref name=":12" /><ref>{{cite journal |last1=Ty |first1=A. U. |last2=See |first2=S. J. |last3=Rao |first3=J. P. |last4=Khoo |first4=J.B.K. |last5=Wong |first5=M. C. |title=Oligodendroglial tumor chemotherapy using "decreased-dose-intensity" PCV: A Singapore experience |journal=Neurology |date=24 January 2006 |volume=66 |issue=2 |pages=247β249 |doi=10.1212/01.wnl.0000194211.68164.a0 |pmid=16434664 |s2cid=31170268 }}</ref> A median survival of up to 16.7 years has been reported for grade II oligodendrogliomas.<ref>{{cite web |url=http://www.neurology.org |title=Neurology |publisher=Neurology |access-date=17 February 2012 |url-status=live |archive-url=https://web.archive.org/web/20120219094513/http://www.neurology.org/ |archive-date=19 February 2012 }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)